Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
| Author | |
| Abstract |
:
Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events. |
| Year of Publication |
:
2019
|
| Journal |
:
The New England journal of medicine
|
| Volume |
:
380
|
| Issue |
:
1
|
| Number of Pages |
:
11-22
|
| Date Published |
:
2019
|
| ISSN Number |
:
0028-4793
|
| URL |
:
https://www.nejm.org/doi/10.1056/NEJMoa1812792?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
|
| DOI |
:
10.1056/NEJMoa1812792
|
| Short Title |
:
N Engl J Med
|
| Download citation |
